Variant report

Variant	esv1815862
Chromosome Location	chr2:76806963-76859486
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:319)
CpG islands
(count:61)
Chromatin interactive
region (count:6)
LncRNA
region (count:3)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:319 , 50 per page) page: 1 2 3 4 5 6 7

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr2:76826892-76827267	HepG2	liver:	n/a	n/a
2	BACH1	chr2:76826863-76827150	H1-hESC	embryonic stem cell:	n/a	n/a
3	BATF	chr2:76826886-76827145	GM12878	blood:	n/a	n/a
4	BHLHE40	chr2:76826921-76827181	K562	blood:	n/a	n/a
5	BHLHE40	chr2:76826935-76827215	GM12878	blood:	n/a	n/a
6	BRCA1	chr2:76826858-76827249	H1-hESC	embryonic stem cell:	n/a	n/a
7	CEBPB	chr2:76826891-76827167	H1-hESC	embryonic stem cell:	n/a	n/a
8	CHD1	chr2:76808522-76808533	GM12878	blood:	n/a	n/a
9	CHD2	chr2:76826886-76827202	H1-hESC	embryonic stem cell:	n/a	n/a
10	CREB1	chr2:76856448-76856731	H1-hESC	embryonic stem cell:	n/a	n/a
11	CTCF	chr2:76826917-76827237	HUVEC	blood vessel:	n/a	n/a
12	CTCF	chr2:76826980-76827130	SK-N-SH_RA	brain:	n/a	n/a
13	CTCF	chr2:76826960-76827110	WERI-Rb-1	eye:	n/a	n/a
14	CTCF	chr2:76827358-76827442	Fibrobl	skin:	n/a	n/a
15	CTCF	chr2:76826960-76827110	GM12865	blood:	n/a	n/a
16	CTCF	chr2:76827320-76827470	GM12864	blood:	n/a	n/a
17	CTCF	chr2:76826724-76827436	GM12878	blood:	n/a	n/a
18	CTCF	chr2:76826913-76827207	Kidney_OC	kidney:	n/a	n/a
19	CTCF	chr2:76826980-76827130	HUVEC	blood vessel:	n/a	n/a
20	CTCF	chr2:76826888-76827197	LNCaP	prostate:	n/a	n/a
21	CTCF	chr2:76827340-76827490	GM12870	blood:	n/a	n/a
22	CTCF	chr2:76827040-76827190	BE2_C	brain:	n/a	n/a
23	CTCF	chr2:76826910-76827170	A549	lung:	n/a	n/a
24	CTCF	chr2:76826940-76827090	MCF-7	breast:	n/a	n/a
25	CTCF	chr2:76826940-76827090	GM12866	blood:	n/a	n/a
26	CTCF	chr2:76827000-76827150	GM12871	blood:	n/a	n/a
27	CTCF	chr2:76826946-76827150	ProgFib	skin:	n/a	n/a
28	CTCF	chr2:76826980-76827130	HRPEpiC	eye:	n/a	n/a
29	CTCF	chr2:76826960-76827110	GM12801	blood:	n/a	n/a
30	CTCF	chr2:76827360-76827510	GM12864	blood:	n/a	n/a
31	CTCF	chr2:76826940-76827090	HCM	heart:	n/a	n/a
32	CTCF	chr2:76826927-76827189	GM20000	blood:	n/a	n/a
33	CTCF	chr2:76826922-76827161	A549	lung:	n/a	n/a
34	CTCF	chr2:76826980-76827130	HepG2	liver:	n/a	n/a
35	CTCF	chr2:76826810-76827289	K562	blood:	n/a	n/a
36	CTCF	chr2:76826920-76827070	A549	lung:	n/a	n/a
37	CTCF	chr2:76826980-76827130	Hela-S3	cervix:	n/a	n/a
38	CTCF	chr2:76826980-76827130	AG04449	skin:	n/a	n/a
39	CTCF	chr2:76826935-76827115	GM12891	blood:	n/a	n/a
40	CTCF	chr2:76826806-76827245	T-47D	breast:	n/a	n/a
41	CTCF	chr2:76826895-76827197	K562	blood:	n/a	n/a
42	CTCF	chr2:76826934-76827210	GM10266	blood:	n/a	n/a
43	CTCF	chr2:76826980-76827130	HL-60	blood:	n/a	n/a
44	CTCF	chr2:76827000-76827150	AG10803	skin:	n/a	n/a
45	CTCF	chr2:76826980-76827130	AG10803	skin:	n/a	n/a
46	CTCF	chr2:76827020-76827170	AG09309	skin:	n/a	n/a
47	CTCF	chr2:76826892-76827198	HepG2	liver:	n/a	n/a
48	CTCF	chr2:76826980-76827130	GM12869	blood:	n/a	n/a
49	CTCF	chr2:76827040-76827190	AG04450	lung:	n/a	n/a
50	CTCF	chr2:76826980-76827130	GM12870	blood:	n/a	n/a

(count:61 , 50 per page) page: 1 2

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr2:76839078-76839128	A549	lung:	n/a
2	chr2:76839078-76839128	GM12878	blood:	n/a
3	chr2:76839078-76839128	AoSMC	blood vessel:	n/a
4	chr2:76839078-76839128	AG04450	lung:	fetal
5	chr2:76839078-76839128	T-47D	breast:	n/a
6	chr2:76839078-76839128	NHDF-neo	bronchial:	n/a
7	chr2:76839078-76839128	HIPEpiC	eye:	n/a
8	chr2:76839078-76839128	CMK	blood:	n/a
9	chr2:76839078-76839128	ProgFib	skin:	n/a
10	chr2:76839078-76839128	NH-A	brain:	n/a
11	chr2:76839078-76839128	SAEC	small airway:	n/a
12	chr2:76839078-76839128	HEK293	kidney:	embryo
13	chr2:76839078-76839128	HRPEpiC	eye:	n/a
14	chr2:76839078-76839128	SK-N-SH_RA	brain:	n/a
15	chr2:76839078-76839128	HCF	heart:	n/a
16	chr2:76839078-76839128	U87	brain:	n/a
17	chr2:76839078-76839128	SKMC	muscle:	n/a
18	chr2:76839078-76839128	HUVEC	blood vessel:	n/a
19	chr2:76839078-76839128	LNCaP	prostate:	n/a
20	chr2:76839078-76839128	BJ	skin:	n/a
21	chr2:76839078-76839128	K562	blood:	n/a
22	chr2:76839078-76839128	PANC-1	pancreas:	n/a
23	chr2:76839078-76839128	IMR90	lung:	fetal
24	chr2:76839078-76839128	Hela-S3	cervix:	n/a
25	chr2:76839078-76839128	MCF10A-Er-Src	breast:	n/a
26	chr2:76839078-76839128	HMEC	breast:	n/a
27	chr2:76839078-76839128	HCPEpiC	choroid plexus:	n/a
28	chr2:76839078-76839128	NT2-D1	testis:	n/a
29	chr2:76839078-76839128	HCM	heart:	n/a
30	chr2:76839078-76839128	Hepatocyte	liver:	n/a
31	chr2:76839078-76839128	AG10803	skin:	n/a
32	chr2:76839078-76839128	RPTEC	kidney:	n/a
33	chr2:76839078-76839128	MCF-7	breast:	n/a
34	chr2:76839078-76839128	Caco-2	colon:	n/a
35	chr2:76839078-76839128	PrEC	prostate:	n/a
36	chr2:76839078-76839128	HRCEpiC	kidney:	n/a
37	chr2:76839078-76839128	HL-60	blood:	n/a
38	chr2:76839078-76839128	AG04449	skin:	fetal
39	chr2:76839078-76839128	SK-N-MC	brain:	n/a
40	chr2:76839078-76839128	NB4	blood:	n/a
41	chr2:76839078-76839128	GM06990	blood:	n/a
42	chr2:76839078-76839128	ovcar-3	ovarian:	n/a
43	chr2:76839078-76839128	BE2_C	brain:	n/a
44	chr2:76839078-76839128	HCT-116	colon:	n/a
45	chr2:76839078-76839128	HepG2	liver:	n/a
46	chr2:76839078-76839128	AG09309	skin:	n/a
47	chr2:76839078-76839128	ECC-1	luminal epithelium:	n/a
48	chr2:76839078-76839128	HPAEpiC	pulmonary alveolar:	n/a
49	chr2:76839078-76839128	PFSK-1	brain:	n/a
50	chr2:76839078-76839128	NHBE	bronchial:	n/a

(count:6 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr2:76424788..76425711-chr2:76826568..76827565,9	MCF-7	breast:
2	chr2:76123697..76124563-chr2:76826531..76827162,2	MCF-7	breast:
3	chr2:76837968..76839669-chr2:76845469..76848246,2	MCF-7	breast:
4	chr2:76014514..76015446-chr2:76826422..76827585,4	MCF-7	breast:
5	chr2:75957100..75957649-chr2:76826627..76827405,2	MCF-7	breast:
6	chr2:76837968..76839669-chr2:76845469..76848246,2	MCF-7	breast:

(count:3 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-MRPL19-18	chr2:76807165-76807212	NONHSAT071820
2	lnc-LRRTM4-5	chr2:76822539-76822804	NONHSAT071821
3	lnc-MRPL19-18	chr2:76814741-76814827	NONHSAT071820

No data

Variant related genes	Relation type
RN7SKP164	TF binding region
RN7SKP164	CpG island

Extended variants
information (count: 2393 )
Associated
traits (count: 56 )

Variant overlapped rSNPs/rCNVs (count:2393 , 50 per page) page: 1 2 3 4 5 6 7 ... 48

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs558709590	chr2:76806994-76806995	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
2	rs577145027	chr2:76806997-76806998	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
3	rs199905127	chr2:76807011-76807012	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
4	rs535323181	chr2:76807041-76807042	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
5	rs553350475	chr2:76807086-76807087	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
6	rs574779943	chr2:76807105-76807106	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
7	rs200414824	chr2:76807155-76807156	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
8	rs563789551	chr2:76807171-76807172	Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
9	rs60612890	chr2:76807173-76807174	Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
10	rs546050608	chr2:76807174-76807175	Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
11	rs564274030	chr2:76807195-76807196	Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
12	rs192666084	chr2:76807204-76807205	Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
13	rs540528428	chr2:76807209-76807210	Active TSS Enhancers Flanking Active TSS	lncRNA	n/a	Overlapped CNVs	n/a
14	rs561785284	chr2:76807214-76807215	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
15	rs80171009	chr2:76807216-76807217	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs183621150	chr2:76807266-76807267	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs568644914	chr2:76807330-76807331	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs372181506	chr2:76807335-76807336	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs144404345	chr2:76807348-76807349	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs186678494	chr2:76807353-76807354	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs200685911	chr2:76807376-76807377	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs77210815	chr2:76807390-76807391	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs553651640	chr2:76807397-76807398	Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs191522625	chr2:76807417-76807418	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs550945844	chr2:76807459-76807460	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs535879894	chr2:76807483-76807484	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs557373557	chr2:76807523-76807524	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs575858412	chr2:76807568-76807569	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs116527417	chr2:76807599-76807600	Active TSS Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs558239940	chr2:76807611-76807612	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs184034167	chr2:76807615-76807616	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs144299781	chr2:76807622-76807623	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs563793335	chr2:76807625-76807626	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs76600667	chr2:76807627-76807628	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs375214666	chr2:76807661-76807662	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs544222141	chr2:76807700-76807701	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs553412980	chr2:76807750-76807751	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs562140057	chr2:76807776-76807777	Active TSS Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs71714891	chr2:76807835-76807836	Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs190123290	chr2:76807853-76807854	Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs548583515	chr2:76807873-76807874	Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
42	rs551064137	chr2:76807890-76807891	Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs567178489	chr2:76807916-76807917	Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
44	rs148739100	chr2:76807918-76807919	Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs181624633	chr2:76807930-76807931	Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
46	rs185412468	chr2:76807934-76807935	Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
47	rs202164024	chr2:76807962-76807963	Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
48	rs568765106	chr2:76807975-76807976	Active TSS Weak transcription Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
49	rs535772450	chr2:76808021-76808022	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs558687628	chr2:76808042-76808043	Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:56)

Disease	PMID	Source
Chronic lymphocytic leukemia	21546498	CNVD
Ovarian neoplasms	16753589	CNVD
Glioblastoma multiforme	17387387	CNVD
Neuroblastoma	17533364	CNVD
Neuroblastoma	18923191	CNVD
Endometrial cancer	22040021	CNVD
Adrenal tumor	17535989	CNVD
Breast cancer	21264507	CNVD
Basal cell lymphoma	17053054	CNVD
Medulloblastoma	17522785	CNVD
Cancer	23418310	CNVD
Medulloblastoma	21979893	CNVD
Breast cancer	17603634	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Ependymoma	16718352	CNVD
Prostate cancer	18632612	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Cancer	20164919	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Follicular lymphoma	20505157	CNVD
Autism	17483303	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Esophageal adenocarcinoma	18519675	CNVD
Medulloblastoma	20607354	CNVD
Autism	22495311	CNVD
Autism	18522746	CNVD
Lung cancer	18438408	CNVD
Neurodevelopmental disorder	22521361	CNVD
Melanoma	18172304	CNVD
Cancer	16751803	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Acute lymphoblastic leukemia	21980252	CNVD
Carcinoma ex pleomorphic adenoma	18828159	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Seminomas	18059402	CNVD
Testicular germ cell tumor	18059402	CNVD
Myeloproliferative neoplasm	20015882	CNVD
Renal cell carcinoma	18765545	CNVD
Myxofibrosarcoma	16751306	CNVD
small cell lung cancer	20016488	CNVD
Acute myeloid leukemia	21251322	CNVD
Mental retardation	17124404	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Cancer	17440070	CNVD
Myelofibrosis	22110671	CNVD
Attention deficit hyperactivity disorder	21324949	CNVD
Breast cancer	16272173	CNVD
Pancreatic ductal adenocarcinoma	19077451	CNVD
Autism	20531469	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	21293372	CNVD

Chromatin state (count:177 , 50 per page) page: 1 2 3 4

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr2:76776000-76807000	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
2	chr2:76802000-76807000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
3	chr2:76802800-76811200	Active TSS	ES-I3 Cell Line	embryonic stem cell
4	chr2:76803400-76807000	Active TSS	H9 Cell Line	embryonic stem cell
5	chr2:76803400-76810600	Active TSS	iPS-15b Cell Line	embryonic stem cell
6	chr2:76804200-76807000	Active TSS	HUES6 Cell Line	embryonic stem cell
7	chr2:76805200-76807000	Active TSS	HUES64 Cell Line	embryonic stem cell
8	chr2:76805200-76807200	Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
9	chr2:76805400-76807000	Active TSS	HUES48 Cell Line	embryonic stem cell
10	chr2:76805800-76807000	Weak transcription	iPS-18 Cell Line	embryonic stem cell
11	chr2:76806800-76807400	Enhancers	H1 Cell Line	embryonic stem cell
12	chr2:76807000-76807400	Enhancers	iPS-18 Cell Line	embryonic stem cell
13	chr2:76807000-76807400	Flanking Active TSS	iPS-20b Cell Line	embryonic stem cell
14	chr2:76807000-76807400	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
15	chr2:76807000-76807600	Flanking Active TSS	H9 Cell Line	embryonic stem cell
16	chr2:76807000-76807600	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
17	chr2:76807000-76807600	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
18	chr2:76807000-76807600	Flanking Active TSS	HUES64 Cell Line	embryonic stem cell
19	chr2:76807000-76810200	Active TSS	ES-WA7 Cell Line	embryonic stem cell
20	chr2:76807200-76807400	Flanking Active TSS	iPS DF 19.11 Cell Line	embryonic stem cell
21	chr2:76807400-76807800	Active TSS	iPS-20b Cell Line	embryonic stem cell
22	chr2:76807400-76808400	Weak transcription	iPS-18 Cell Line	embryonic stem cell
23	chr2:76807400-76826800	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
24	chr2:76807600-76807800	Enhancers	H9 Cell Line	embryonic stem cell
25	chr2:76807600-76807800	Active TSS	HUES48 Cell Line	embryonic stem cell
26	chr2:76807600-76808800	Active TSS	HUES64 Cell Line	embryonic stem cell
27	chr2:76807600-76809600	Active TSS	HUES6 Cell Line	embryonic stem cell
28	chr2:76807800-76808000	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
29	chr2:76807800-76808400	Weak transcription	H9 Cell Line	embryonic stem cell
30	chr2:76807800-76808800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
31	chr2:76808000-76808600	Active TSS	HUES48 Cell Line	embryonic stem cell
32	chr2:76808400-76808600	Enhancers	H9 Cell Line	embryonic stem cell
33	chr2:76808600-76808800	Enhancers	iPS-18 Cell Line	embryonic stem cell
34	chr2:76808600-76809200	Flanking Active TSS	HUES48 Cell Line	embryonic stem cell
35	chr2:76808600-76824200	Weak transcription	H9 Cell Line	embryonic stem cell
36	chr2:76808800-76809600	Active TSS	iPS-20b Cell Line	embryonic stem cell
37	chr2:76808800-76822200	Weak transcription	HUES64 Cell Line	embryonic stem cell
38	chr2:76809200-76809800	Active TSS	HUES48 Cell Line	embryonic stem cell
39	chr2:76809600-76809800	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
40	chr2:76809600-76810000	Weak transcription	iPS-20b Cell Line	embryonic stem cell
41	chr2:76809800-76810600	ZNF genes & repeats	HUES6 Cell Line	embryonic stem cell
42	chr2:76809800-76811400	Weak transcription	HUES48 Cell Line	embryonic stem cell
43	chr2:76810000-76810400	ZNF genes & repeats	iPS-20b Cell Line	embryonic stem cell
44	chr2:76810200-76813600	Weak transcription	ES-WA7 Cell Line	embryonic stem cell
45	chr2:76810400-76826200	Weak transcription	iPS-20b Cell Line	embryonic stem cell
46	chr2:76810600-76811000	Enhancers	iPS-15b Cell Line	embryonic stem cell
47	chr2:76811000-76813000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
48	chr2:76811200-76813000	Weak transcription	ES-I3 Cell Line	embryonic stem cell
49	chr2:76811400-76811800	Enhancers	HUES48 Cell Line	embryonic stem cell
50	chr2:76811800-76816000	Weak transcription	HUES48 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links